EGPA presenting as sudden cardiac arrest: a case report and review of cardiac manifestations
ЭГПА, манифестировавшая внезапной остановкой сердца: описание клинического случая и обзор кардиальных проявлений
2026-01-15
SCID: 54.1/ae6ztxfq
Discuss with AI
Adams-Stokes syndromeComplete heart blockEosinophilic granulomatosis with polyangiitisMepolizumabThird-degree atrioventricular block
Figures from the paper
Abstract (AI)
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis in which cardiac involvement is a primary cause of mortality. Complete heart block presenting as Adams-Stokes syndrome is a rare but critical complication. Notably, to our knowledge, EGPA initially manifesting as Adams-Stokes syndrome has not been previously documented, based on a comprehensive review of the literature. We report a 27-year-old female presenting with recurrent syncope and seizures. Laboratory tests revealed significant eosinophilia (49.5%), and cardiac workup confirmed third-degree atrioventricular block. A diagnosis of EGPA was established based on the 2022 ACR/EULAR criteria (score=13). Emergency treatment involved temporary pacing and methylprednisolone pulse therapy, followed by mepolizumab induction. Sinus rhythm recovered within 24 hours. During a two-month follow-up, the patient maintained remission with normalized eosinophil counts and improved cardiac function. This case highlights the importance of including EGPA in the differential diagnosis of unexplained high-grade heart block and supports the efficacy of early immunosuppressive therapy in reversing life-threatening cardiac complications.
Key Findings
1
A 27-year-old woman with recurrent syncope and seizures had marked eosinophilia (49.5%) and was diagnosed with EGPA using the 2022 ACR/EULAR criteria (score=13).
2
At two-month follow-up, the patient remained in remission with normalized eosinophil counts and improved cardiac function.
3
EGPA can initially present as Adams–Stokes syndrome caused by complete third-degree atrioventricular block, a presentation not previously documented by the authors’ literature review.
4
EGPA should be considered in unexplained high-grade heart block, and early immunosuppressive treatment may reverse life-threatening cardiac complications.
5
Emergency temporary pacing and methylprednisolone pulse therapy, followed by mepolizumab induction, restored sinus rhythm within 24 hours.
Research Object
Eosinophilic granulomatosis with polyangiitis (EGPA) with cardiac involvement presenting as complete heart block/Adams–Stokes syndrome
Research Subject
The cardiac manifestations of EGPA, particularly the mechanism and reversibility of life-threatening complete atrioventricular block and associated syncope/seizures with early immunosuppressive therapy
Publication Details
Publication Date
2026-01-15
Journal
Publisher
ISSN
Cited by
1
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest